Incro Pharmaceuticals Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Incro Pharmaceuticals Corporation - overview
Established
2015
Location
-, CA, US
Primary Industry
Pharmaceuticals
About
Founded in 2015, Incro Pharmaceuticals Corporation is based in Santa Fe, California. The firm operates as a developer of drugs used to block a protein called RIP1.
Current Investors
Denali Therapeutics Inc.
Primary Industry
Pharmaceuticals
Sub Industries
Drug Stores/Convenience Stores, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Incro Pharmaceuticals Corporation - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.